Долгая жизнь с муковисцидозом. Коллектив авторов
Чтение книги онлайн.
Читать онлайн книгу Долгая жизнь с муковисцидозом - Коллектив авторов страница 29
Название: Долгая жизнь с муковисцидозом
Автор: Коллектив авторов
Издательство: Автор
Жанр: Здоровье
isbn: 978-5-4461-0329-4
isbn:
209
Efrati O, Bylin I, Segal E, et al. Outcome of patients with cystic fibrosis admitted to the intensive care unit: is invasive mechanical ventilation a risk factor for death in patients waiting lung transplantation? Heart Lung 2010; 39: 153-9.
210
Jones A, Bilton D, Evans TW, et al. Predictors of outcome in patients with cystic fibrosis requiring endotracheal intubation. Respirology 2013; 18: 630-6.
211
Nosotti M, Rosso L, Tosi D, et al. Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation. Interact CardiovasoThorac Surg 2013; 16:55-9.
212
Fuehner T, Kuehn C, Hadem J, etal. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185: 763-8.
213
Szaff M, Høiby N. Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis. Acta Paediatr Scand 1982; 71: 821–6.
214
Hoiby N. Cystic fibrosis: infection. Schweiz Med Wochenschr 1991; 121:105-9.
215
Andersen DH. Therapy and prognosis of fibrocystic disease of the pancreas. Pediatrics 1949; 3: 406-17.
216
Høiby N. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand В Microbiol Immunol 1974; 82: 541-50.
217
Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30(Suppl): 453-64.
218
Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23: 299–323.
219
Hauser AR, Jain M, Bar-Meir M, et al. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 2011; 24: 29–70.
220
Courtney JM, Bradley J, Mccaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007; 42: 525-32.
221
Courtney JM, Dunbar KE, McDowell A, et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004; 3: 93-8.
222
Courtney JM, Dunbar KE, McDowell A, et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004; 3: 93-8.
223
Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-10.
224
Tablan ОС, Martone WJ, Doershuk CF et al. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis.
225
Cystic Fibrosis Foundation. Patient registry annual data report 2012. Bethesda: Cystic Fibrosis Foundation; 2012. http://www.cff.org/UploadedFiles/research/Clinical Research/PatientRegistryReport/2012-CFF-Patient-Registry.pdf
226
European Cystic Fibrosis Society. ECFS patient registry. Annual data report 2010. Karup: European Cystic Fibrosis Society; 2010. https://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFSPR_Report10_v12014_final_020617.pdf
227
Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23: 299–323.
228
Vandamme P, Holmes B, Vancanneyt M, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacterid 1997; 47: 1188-200.
229
Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23: 299–323.
230
Holmes A, Nolan R, Taylor R, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999; 179: 1197-205.
231
Sun L, Jiang RZ, Steinbach S, et al. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1995; 1: 661-6.
232
Saiman L, Siegel JD, LiPuma JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014; 35 (Suppl 1):S1-S67.
233
Savant AP, O'Malley C, Bichl S, et al. Improved patient safety through reduced airway infection rates in a paediatric cystic fibrosis programme after a quality improvement effort to enhance infection prevention and control measures. BMJ Quality Safety 2014;23(Suppl1):i73-i80.
234
Alexander BD, Petzold EW, Reller LB, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008; 8: 1025-30.
235
Murray S, Charbeneau J, Marshall ВС, et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J RespirCrit Care Med 2008; 178: 363-71.
236
Gilchrist FJ, Webb AK, Bright-Thomas RJ, et al. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids. J Cyst Fibros 2012; 11:458-60.
237
Uluer СКАЧАТЬ